When a company's share price crashes in the wake of a public health scare, it can take a long time for the business to rebuild a reputation...
Drugmaker Johnson & Johnson (NYSE: JNJ) announced a $10 billion stock buyback program today (Tuesday) amid a mixed Q3 earnings...
The key to tech investing depends on five criteria for identifying the best stock. And we've got one poised to double your money in three...
Over the past few weeks, one "clinical stage" pharma firm after another has seen its stock price rise and plummet on rumors about who has the...
Best investments for the week ending Jan. 24, 2014: Stocks tumbled last week as investors fled global markets amid soft...
This year activist investors have been busier than ever, but...
Third-quarter earnings season has picked up, with a number of companies posting earnings today before the opening bell and two tech giants set...
On Sunday, the world's largest independent biotechnology company, Amgen Inc. (Nasdaq:
If you looked at just the first-quarter results you could be forgiven for thinking that everything in the stock market is rosy. The